The Vanessa Moss Prize: celebrating research into cancer health disparities
To help improve the quality of breast cancer care globally, a collaboration of leading partners has created the Grand Rounds in Breast Cancer series of educational webinars. This session with ecancer enables learners the opportunity to discuss controversies, real-life challenges and effective application of existing knowledge.
Prof Helena Earl (University of Cambridge, Cambridge, UK) presents her talk on tailoring breast cancer treatments to country resources and patients. She highlights the importance of value-based care within the healthcare system and reviews the targeted treatments for breast cancer.
Prof Sabine Siesling (University of Twente, Twente, Netherlands) looks at the risk predictions of tailored oncology for breast cancer patients. Prof Siesling evaluates the prediction model and emphasises the significance of follow-up.
The discussion is continued with both speakers and Dr Didier Verhoeven (University of Antwerp, Antwerp, Belgium) addressing the issue of insufficient funding for research and development.
The next webinar will take place on the 29th September 2023 covering the cost-benefit analysis of new cancer medicines: The difficult choices of governments.
The Vanessa Moss Prize: celebrating research into cancer health disparities
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adjuvant radiotherapy has no benefit following radical prostatectomy
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 4th - 10th, 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital